ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Alternative Immunotherapy Drug More Effective than Current Standard of Care in Treating Advanced Melanoma after … – PR Newswire (press release)

Continue reading

2017-09-10 Michael Zand NEWS

Indonesia wants to up stem cell work – PNG Industry News (press release) (subscription)


PR Newswire (press release)

Alternative Immunotherapy Drug More Effective than Current Standard of Care in Treating Advanced Melanoma after …
PR Newswire (press release)
NEW YORK, Sept. 10, 2017 /PRNewswire-USNewswire/ — The immunotherapy drug nivolumab is safer and more effective than ipilimumab—the current standard of care—in treating patients with resected stage III and stage IV melanoma, according to an …

Continue reading

2017-09-10 Michael Zand NEWS

Indonesia wants to up stem cell work – PNG Industry News (press release) (subscription)


PNG Industry News (press release) (subscription)

Indonesia wants to up stem cell work
PNG Industry News (press release) (subscription)
Indonesia wants to up stem cell work. INTERNATIONAL support and competitive regulatory policies in key growth areas, such as stem cell research, are helping drive development in Indonesia’s research and development industry. Staff Reporter.

Continue reading

2017-09-10 Michael Zand NEWS

Bringing Back the Dead – Highlands Current

Highlands CurrentBringing Back the DeadHighlands CurrentDe-extinction is usually thought of as part of the larger field of synthetic biology, and synthetic biology is rife with values questions. Synthetic biology might allow you not only to re-create e… Continue reading

2017-09-10 Michael Zand NEWS

Dr Lee Newcomer on Policy Decisions as New Immunotherapy Agents Are Developed – AJMC.com Managed Markets Network

AJMC.com Managed Markets NetworkDr Lee Newcomer on Policy Decisions as New Immunotherapy Agents Are DevelopedAJMC.com Managed Markets NetworkLee N. Newcomer, MD, MHA, senior vice president of oncology and genetics at UnitedHealthcare, discusses off-lab… Continue reading

2017-09-10 Michael Zand NEWS

First US FDA approval of CAR-T therapy hikes expectations for Korean biotech ventures – The Korea Herald

The Korea HeraldFirst US FDA approval of CAR-T therapy hikes expectations for Korean biotech venturesThe Korea HeraldCAR-T cell therapies are widely expected to form a new wave in the realm of cancer treatments, going beyond traditional methods includi… Continue reading

2017-09-10 Michael Zand NEWS

CRISPR technology used to change flower color – Science Daily

Science DailyCRISPR technology used to change flower colorScience DailyIn a world-first, Japanese scientists have used the revolutionary CRISPR, or CRISPR/Cas9, genome- editing tool to change flower colour in an ornamental plant. Researchers from the … Continue reading

2017-09-09 Michael Zand NEWS

CD19-Specific CAR T-Cell Therapy Effective in Ibrutinib-Refractory CLL – Cancer Network

CD19-Specific CAR T-Cell Therapy Effective in Ibrutinib-Refractory CLLCancer NetworkAnti-CD19 chimeric antigen receptor (CAR)-modified T-cell therapy was highly effective in patients with high-risk chronic lymphocytic leukemia (CLL) who had previously … Continue reading

2017-09-09 Michael Zand NEWS
  • 1
  • …
  • 1,224
  • 1,225
  • 1,226
  • 1,227
  • 1,228
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

PNG Industry News (press release) (subscription)

Indonesia wants to up stem cell work
PNG Industry News (press release) (subscription)
Indonesia wants to up stem cell work. INTERNATIONAL support and competitive regulatory policies in key growth areas, such as stem cell research, are helping drive development in Indonesia’s research and development industry. Staff Reporter.